Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Revenue: 2019-2024

Historic Revenue for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $259.2 million.

  • Maravai Lifesciences Holdings' Revenue fell 39.69% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $192.4 million, marking a year-over-year decrease of 30.47%. This contributed to the annual value of $259.2 million for FY2024, which is 10.30% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Revenue of $259.2 million as of FY2024, which was down 10.30% from $288.9 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Revenue ranged from a high of $883.0 million in FY2022 and a low of $259.2 million during FY2024.
  • Its 3-year average for Revenue is $477.0 million, with a median of $288.9 million in 2023.
  • Its Revenue has fluctuated over the past 5 years, first soared by 181.33% in 2021, then plummeted by 67.28% in 2023.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Revenue stood at $284.1 million in 2020, then spiked by 181.33% to $799.2 million in 2021, then increased by 10.48% to $883.0 million in 2022, then slumped by 67.28% to $288.9 million in 2023, then decreased by 10.30% to $259.2 million in 2024.